Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Combs Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
02/09/2023 4 Combs Andrew (EVP, Head of Chemistry) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 135,000 options to buy @ $7.2, valued at $972k
04/04/2022 4 Combs Andrew (EVP, Head of Chemistry) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Exercised 36,062 shares @ $1.89, valued at $68.2k
Exercised 36,062 options to buy @ $1.89, valued at $68.2k
02/17/2022 4 Combs Andrew (EVP, Head of Chemistry) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 100,000 options to buy @ $10.58, valued at $1.1M
12/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Combs Andrew (EVP, Head of Chemistry) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Bought 1,000 shares @ $19, valued at $19k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy